These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1296825)

  • 1. Effects of milrinone on lung water content in dogs with acute pulmonary hypertension.
    Tanaka H; Tajimi K; Matsumoto A; Kobayashi K
    J Pharmacol Toxicol Methods; 1992 Dec; 28(4):201-8. PubMed ID: 1296825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milrinone improves arterial oxygenation in dogs with acute lung injury induced by oleic acid.
    Tanaka H; Tajimi K; Kobayashi K
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):806-10. PubMed ID: 10598123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension.
    Tanaka H; Tajimi K; Moritsune O; Kobayashi K; Okada K
    Crit Care Med; 1991 Jan; 19(1):68-74. PubMed ID: 1986892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension.
    Chen EP; Bittner HB; Davis RD; Van Trigt P
    Transplantation; 1997 Jan; 63(2):209-16. PubMed ID: 9020319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension.
    Chen EP; Bittner HB; Davis RD; Van Trigt P
    J Heart Lung Transplant; 1998 Jul; 17(7):669-78. PubMed ID: 9703231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure.
    Hentschel T; Yin N; Riad A; Habbazettl H; Weimann J; Koster A; Tschope C; Kuppe H; Kuebler WM
    Anesthesiology; 2007 Jan; 106(1):124-31. PubMed ID: 17197854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
    Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
    J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates.
    Sablotzki A; Starzmann W; Scheubel R; Grond S; Czeslick EG
    Can J Anaesth; 2005 Dec; 52(10):1076-82. PubMed ID: 16326679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension.
    Lobato EB; Beaver T; Muehlschlegel J; Kirby DS; Klodell C; Sidi A
    Br J Anaesth; 2006 Mar; 96(3):317-22. PubMed ID: 16443640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs.
    Hashiba E; Hirota K; Yoshioka H; Hashimoto Y; Kudo T; Sato T; Matsuki A
    Anesth Analg; 2000 Apr; 90(4):790-4. PubMed ID: 10735777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
    Deb B; Bradford K; Pearl RG
    Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone decreases both pulmonary arterial and venous resistances in the hypoxic dog.
    Kato R; Sato J; Nishino T
    Br J Anaesth; 1998 Dec; 81(6):920-4. PubMed ID: 10211020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism: a comparison with those of dopamine and dobutamine.
    Tanaka H; Tajimi K; Matsumoto A; Kobayashi K
    Clin Exp Pharmacol Physiol; 1990 Oct; 17(10):681-90. PubMed ID: 2272126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prostacyclin and milrinone on pulmonary hemodynamics in newborn lambs with persistent pulmonary hypertension induced by ductal ligation.
    Rashid N; Morin FC; Swartz DD; Ryan RM; Wynn KA; Wang H; Lakshminrusimha S; Kumar VH
    Pediatr Res; 2006 Nov; 60(5):624-9. PubMed ID: 16988189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension.
    Chen EP; Craig DM; Bittner HB; Davis RD; Van Trigt P
    Circulation; 1998 Apr; 97(16):1606-12. PubMed ID: 9593566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
    Cheng D; Chen W; Jiang J
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance.
    Clarke WR; Uezono S; Chambers A; Doepfner P
    Pulm Pharmacol; 1994 Apr; 7(2):81-9. PubMed ID: 8081075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.